BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Northwest Biotherapeutics Announces Development Completed for Initial Production Capacity of Sawston, UK Facility

  Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that development of the initial production capacity of the Company’s Sawston, UK

  March 16, 2021

   · 

  9 min read
• BioCapital

  New Association for Molecular Pathology Report Reignites Effort for Appropriate Reimbursement for Professional Analysis, Interpretation, and Reporting of Molecular Diagnostic Testing Procedures

  The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its qualitative and quantitative “Analysis of Professional Work Effort in Molecular Test Interpretation Report.”

  March 16, 2021

   · 

  3 min read
• iCo Therapeutics, Inc. Announces Agreement for in Vivo Testing of iCo-019 on SARS-CoV-2

  “We are excited for this next phase in our development of iCo-019 to begin,” said William Jarosz, the Chief Executive Officer of iCo.

  March 16, 2021

   · 

  4 min read
• Business

  Allen Institute Adds Leading Authority on Bioethics to Board of Directors

  Alta Charo brings background and expertise in the law, bioethics and government relations to the nonprofit research organization’s governing board

  March 16, 2021

   · 

  2 min read
• Business

  IONETIX Announces Targeted Alpha Therapy Manufacturing Center

  IONETIX, a leading cyclotron technology and isotope manufacturing company, has acquired a 10,300 sq. ft. facility in Lansing, MI for its new Targeted Alpha Radionuclide Manufacturing Center.

  March 16, 2021

   · 

  2 min read
• BRAIN-AF Study Receives Canadian Institutes of Health Research GrantThis money will allow for the expansion of remote recruitment of participants for this research that aims to treat the heart and help the brain

  The Montreal Heart Institute (MHI) announces that the BRAIN-AF study has received a $1.4 million grant from the Canadian Institutes of Health Research.

  March 16, 2021

   · 

  3 min read
• Business

  Ryvu Therapeutics reports financial results for 2020

  Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, reported today its financial results for 2020 highlighting the increase in revenues to PLN 37.3 million,

  March 16, 2021

   · 

  12 min read